Testosterone · Depression · Sleep apnoea
The testosterone, sleep apnoea, and depression triangle
There is a three-way relationship between testosterone, sleep architecture, and depression that is well-evidenced in the literature and largely overlooked in clinical practice. Patients with overlapping sleep, hormonal, and mood disorders are routinely assessed by each specialty separately — endocrinology for low testosterone, psychiatry for depression, sleep medicine for snoring — with each clinician treating their component while the others persist.
Sleep and testosterone: bidirectional
The majority of testosterone release in men occurs during slow-wave and REM sleep. Sleep deprivation directly suppresses testosterone production — restricting sleep to 5 hours per night for one week reduces daytime testosterone levels by approximately 10–15%, comparable to ageing 10–15 years (Leproult & Van Cauter, JAMA 2011). Conversely, low testosterone disrupts sleep architecture: it reduces REM sleep, increases arousal, and in men is an independent risk factor for both central and obstructive sleep apnoea.
Sleep apnoea and the hormonal cascade
OSA causes sleep fragmentation, intermittent hypoxia, and sympathetic nervous system activation — all of which suppress the hypothalamic-pituitary-gonadal (HPG) axis. Men with moderate-to-severe OSA commonly have clinically significant testosterone deficiency as a consequence. Critically, treating the sleep apnoea — rather than simply replacing testosterone — can restore hormonal function in many cases. Testosterone replacement without addressing the underlying sleep disorder may produce incomplete or unsustained benefit.
The depression link
Low testosterone is an independent risk factor for depression in both sexes. Sleep disruption dramatically increases depression risk — both via biological mechanisms (disrupted circadian glucocorticoid rhythms, reduced serotonin synthesis) and through the cognitive and functional consequences of daytime fatigue. The result is patients who cycle between antidepressant prescribing, testosterone clinics, and sleep referrals without anyone integrating the picture. Treating sleep apnoea has been shown to improve mood, reduce depressive symptoms, and normalise testosterone — all without additional pharmacological intervention in a subset of patients.
Key references
- Leproult R & Van Cauter E. Effect of 1 week of sleep restriction on testosterone levels in young healthy men. JAMA 2011;305(21):2173–2174.
- Luboshitzky R et al. Disruption of the nocturnal testosterone rhythm by sleep fragmentation in normal men. J Clin Endocrinol Metab 2002;86(3):1134–1139.
- Gambineri A et al. Obesity and the polycystic ovary syndrome. J Clin Endocrinol Metab 2003;87(4):1553–1561.
- Walker BR. Glucocorticoids and cardiovascular disease. Best Pract Res Clin Endocrinol Metab 2007;21(3):341–356.
No GP referral needed. Available UK-wide. Usually within 1–2 weeks.